Cargando…
New Generation Vaccines for COVID-19 Based on Peptide, Viral Vector, Artificial Antigen Presenting Cell, DNA or mRNA
At present, effective vaccines have been developed as the most successful approaches for preventing widespread infectious disease. The global efforts are focusing with the aim of eliminating and overcoming the Coronavirus Disease 2019 (COVID-19) and are developing vaccines from the date it was annou...
Autores principales: | Rezaei, Marzieh, Nazari, Mahboobeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Research Institute
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017465/ https://www.ncbi.nlm.nih.gov/pubmed/35509358 http://dx.doi.org/10.18502/ajmb.v14i1.8167 |
Ejemplares similares
-
Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines
por: Rijkers, Ger T., et al.
Publicado: (2021) -
mRNA-based vs viral vector-based COVID-19 vaccines
Publicado: (2021) -
Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2022) -
Generation of non-human primate CAR Tregs using artificial antigen-presenting cells, simian tropic lentiviral vectors, and antigen-specific restimulation
por: Ellis, Gavin I., et al.
Publicado: (2022) -
Neo-Antigen mRNA Vaccines
por: Esprit, Arthur, et al.
Publicado: (2020)